Try it
Pharmacology · Chemotherapy: fluorouracil and DPD deficiency
Sample itemA 60-year-old woman with colon cancer develops severe mucositis, diarrhoea and neutropenia within days of her first fluorouracil infusion. Which enzyme deficiency is most likely?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Dihydropyrimidine dehydrogenase
Dihydropyrimidine dehydrogenase degrades more than 80% of an administered dose of fluorouracil, and deficiency (DPYD variants) leads to severe, sometimes fatal toxicity. Capecitabine, a prodrug of fluorouracil, shares the risk. Testing for DPYD variants before treatment is recommended in many centres.
Option by option
A. UDP-glucuronosyltransferase 1A1
UGT1A1 variants cause severe irinotecan toxicity.
B. Thiopurine methyltransferase
TPMT deficiency causes toxicity with mercaptopurine and azathioprine.
C. CYP2D6
CYP2D6 variants alter activation of tamoxifen and codeine.
D. Dihydropyrimidine dehydrogenase (correct)
Correct. Reduced catabolism raises fluorouracil exposure and toxicity.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?